Quinethazone
|  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information | 
| Routes of administration | Oral | 
| ATC code | C03BA02 (WHO) | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 73-49-4  | 
| PubChem (CID) | 6307 | 
| IUPHAR/BPS | 7289 | 
| DrugBank | DB01325  | 
| ChemSpider | 6068  | 
| UNII | 455E0S048W  | 
| KEGG | D00461  | 
| ChEMBL | CHEMBL1532  | 
| ECHA InfoCard | 100.000.729 | 
| Chemical and physical data | |
| Formula | C10H12ClN3O3S | 
| Molar mass | 289.739 g/mol | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
| (verify) | |
Quinethazone (INN, brand name Hydromox) is a thiazide-like diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
References
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.